Blockade of cocaine-induced increases in adrenocorticotrophic hormone and cortisol does not attenuate the subjective effects of smoked cocaine in humans

Behavioural Pharmacology

Volumn 10, Issue 5, 1999, Pages 523-529

  Ward, Amie S ^a   Collins, E D ^a   Haney, M ^a   Foltin, R W ^a   Fischman, M W ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

ACTH; Cardiovascular effects; Cocaine; Cortisol; Dexamethasone; Human; Subjective effects

Indexed keywords

COCAINE; CORTICOTROPIN; DEXAMETHASONE; HYDROCORTISONE;

ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DISCRIMINATIVE STIMULUS; DRUG ABUSE; DRUG EFFECT; FEMALE; HEART RATE; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INHALATIONAL DRUG ADMINISTRATION; MALE; NORMAL HUMAN; PRIMATE; REINFORCEMENT;

EID: 0032860395     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-199909000-00010     Document Type: Article

References (25)

1. Broadbear JH, Winger GD, Cicero TJ, Woods JH (1999a). The effects of self-administered cocaine on plasma ACTH and cortisol in male rhesus monkeys. J Pharmacol Exp Ther 289:1641-1647.
2. Broadhear JH, Winger GD, Woods JH (1999b). Cocaine reinforced responding in rhesus monkeys: pharmacological attenuation of the HPA response. J Pharmacol Exp Ther (in press).
3. Calogero AE, Gallucci WT, Kling MA, Chrousos GP, Gold PW (1989). Cocaine stimulates rat hypothalamic corticotropin-releasing hormone in vitro. Brain Res 505:7-11.
4. Carroll BJ, Feinberg M, Greden JF et al. (1981). A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility. Arch Gen Psychiatry 38:15-22.
5. Capasso A, Di Giannuari A, Loizzo A, Pieretti S, Sorrentino L (1995). Dexamethasone pretreatment reduces the psychomotor stimulant effects induced by cocaine in mice. Prog Neuropsychopharmacol Biol Psychiatry 19:1063-1079.
6. Erb S, Shaham Y, Stewart J (1998). The role of corticotropin-releasing factor and corticosterone in stress-and cocaine-induced relapse to cocaine seeking in rats. J Neurosci 18:5529-5536.
7. Foltin RW, Fischman MW (1991). Smoked and intravenous cocaine in humans: acute tolerance, cardiovascular and subjective effects. J Pharmacol Exp Ther 257:247-261.
8. Foltin RW, Fischman MW (1992). Self-administration of cocaine by humans: choice between smoked and intravenous cocaine. J Pharmacol Exp Ther 261:841-849.
9. Foltin RW, Fischman MW, Nestadt G, Stromberger H, Cornell EE, Pearlson GD (1990). Demonstration of naturalistic methods for cocaine smoking by human volunteers. Drug Alcohol Depend 26:145-154.
10. Goeders N (1997). A neuroendocrine role in cocaine reinforcement. Psychoneuroendocrinology 22:237-259.
11. Goeders N, Guerin G (1996). Effects of surgical and pharmacological adrenalectomy on the initiation and maintenance of intravenous cocaine self-administration in rats. Brain Res 722:145-152.
12. Goeders NE, Peltier RL, Guerin GF (1998). Ketoconazole reduces low-dose cocaine self-administration in rats. Drug Alcohol Depend 53: 67-78.
13. Goland RS, Conwell IM, Warren WB, Wardlaw SL (1992). Placental corticotropin-releasing hormone and pituitary-adrenal function during pregnancy. Neuroendocrinology 56:742-749.
14. Mantero F, Boscaro M (1992). Glucocorticoid-dependent hypertension. J Steroid Biochem Mol Biol 43:409-413.
15. Mello NK, Mendelson JH (1997). Cocaine's effects on neuroendocrine systems: clinical and preclinical studies. Pharmacol Biochem Behav 57:571-599.
16. Mendelson JH, Sholar M, Mello NK, Tcoh SK, Sholar JW (1998). Cocaine tolerance: behavioral, cardiovascular, and neuroendocrine function in men. Neuropsychopharmacology 18:263-271.
17. Moldow RL, Fischman AJ (1987). Cocaine induced secretion of ACTH, beta-endorphin, and corticosterone. Peptides 8:819-822.
18. Piazza PV, Le Moal M (1996). Pathophysiological basis of vulnerability to drug abuse: role of an interaction between stress, glucocorticoids, and dopaminergic neurons. Annu Rev Pharmacol Toxicol 36:359-378.
19. Piazza P, Marinelli M, Jodogne C et al. (1994). Inhibition of corticosterone synthesis my metyrapone decreases cocaine-induced locomotion and relapse of cocaine self-administration. Brain Res 658:259-264.
20. Rivier C, Vale W (1987). Cocaine stimulates adrenocorticotropin (ACTH) secretion through a cortico-tropin releasing factor (CRF)-mediated mechanism. Brain Res 422:403-406.
21. Sarnyai Z, Mello NK, Mendelson JH, Nguyen P, Erös-Sarnyai M (1995). Effects of cocaine and corticotropin-releasing factor (CRF) on pulsatile ACTH release in ovariectomized rhesus monkeys. J Clin Endocrinol Metab 80:2745-2751.
22. Sirnar MR, Saphier D, Goeders N (1997). Dexamethasone suppression of the effects of cocaine on adrenocortical secretion in Lewis and Fischer rats. Psychoneuroendocrinology 22:141-153.
23. Tallarida RJ, Murray RB (1981). Manual of Pharmacological Calculations with Computer Programs. New York: Springer.
24. Ward AS, Collins ED, Haney M, Foltin RW, Fischman MW (1998). Ketoconazole attenuates the cortisol reponse but not the subjective effects of smoked cocaine in humans. Behav Pharmacol 9:577-586.
25. Whilworth JA, Saines D, Thatcher R, Butkus A, Scoggins BA (1983) Blood pressure and metabolic effects of ACTH in normotensive and hypertensive man. Clin Exp Hypertens 5:501-522.